Top 9 biotech startups from the Disrupt Startup Battlefield

Every year, TechCrunch’s Startup Battlefield pitch contest attracts thousands of applicants. We count the programs so far Top 200 competitorsand among them, the top 20 compete on the main stage to become the winner, taking part in the Startup Battlefield Cup with a cash prize of $100,000. But the rest of the 180 have all confused us and in their groups and competed in their competitions.

Here’s the full list of biotech and pharma Startup Battlefield 200 nominees, along with a note on why they made it to the competition.

CasNx

What it does: CasNx has developed a new way to treat viruses for organs from organ donors.

Why it matters: The inventors have developed CRISPR gene-editing tools that remove viruses and insert “full donor” markers while the organ is stored outside the body.

Chipiron

What it does: Chipiron is building a lightweight and inexpensive, fully open MRI machine the goal is to make MRI cancer diagnosis more accessible.

Why it matters: The medical MRI system is being built using a superconducting quantum interference device (SQUID), a highly sensitive magnetometer capable of measuring extremely weak magnetic fields, which are widely used in antennas.

Guaranteed

What it does: Exactics is developing a platform that creates fast cognitive tests.

Why it matters: Exactics is trying to make screening tools more available to consumers, starting with home testing for Lyme disease, and other disease testing kits on the road.

Lumos Strategies OÜ

What it does: Lumos developed a high-speed electronic device called Avara, which targets red blood cells.

Why it matters: Avara is designed to provide mild, non-invasive “stimulant therapy” for sleep, relaxation, and recovery.

Miracles

What it does: Miraqules made a nanotechnology in powder form that mimics blood clotting proteins .

Why it matters: This technology provides immediate blood clotting and is a unique, potentially life-saving alternative to traditional therapies, especially when treating patients at the site of injury.

Nephrogen

What it does: Nephrogen is developing treatments for kidney disease.

Why it matters: Nephrogen is solving the most difficult part of the problem when it comes to gene therapy. Its technology uses AI to precisely target genetic changes to the specific kidney cells that cause the disease.

PracticePro

What it does: PraxisPro is an AI-powered training solution for sales and marketing in the life sciences industry.

Why it matters: The program offers a comprehensive certification program, complete with tests and real-time analysis to ensure that those representing the life sciences industry are ready to do so.

Reme-D

What it does: Reme-D is developing a reliable and cost-effective test that targets vulnerable areas.

Why it matters: Reme-D is developing a rapid diagnostic test that is not only affordable but also stable in hot and humid environments.

Surgical Technologies

What it does: Surgeons have developed an approved technique that secures endotracheal (ET) tubes safely and reliably.

Why it matters: This device makes ET tubes, flexible tubes that are inserted into the mouth or nose during surgery or other treatments, safe and comfortable for patients.